Jam
-
Integrated BioPharma Announces Results for Quarter Ended September 30, 2025
Integrated BioPharma (INBP) reported its Q3 2025 financial results, revealing a 6.6% revenue decrease to $12.7 million compared to Q3 2024. Gross profit, operating income, and net income also declined. A significant concern is the high customer concentration, with the top two clients accounting for approximately 87% of revenue, up from 85% in the prior year. Despite decreased revenue and profits, INBP still maintained a net income of $0.12 million, or $0.00 diluted per share.
-
Northborne Partners Advises Disdero Lumber on Sale to BlueLinx
BlueLinx Holdings has acquired Disdero Lumber Company, a specialty lumber distributor, to expand its presence in the high-margin, premium building materials market. Disdero, known for supplying high-end residential projects, will enhance BlueLinx’s product offerings and supplier relationships. Northborne Partners advised Disdero’s parent company, Tumac Lumber, on the deal. The acquisition reflects the ongoing consolidation trend in the lumber distribution industry as companies seek greater scale and market reach.
-
Diversified Energy: Results of Court and General Meetings
Diversified Energy (DEC) shareholders approved a UK scheme to re-domicile under a new Delaware parent (NewCo) at meetings on November 10, 2025. The Court Meeting resolution passed with 71.23% of shares voting for the scheme. Shareholders also approved the 2025 Equity Incentive Plan (94.83% For) and special resolutions to effect the scheme (99.72% For). Completion is subject to High Court sanction and regulatory approvals, with NewCo listings expected around November 21-24, 2025.
-
CrowdStrike Leads in 2025 KuppingerCole ITDR Leadership Compass
CrowdStrike has been named the Overall Leader in the 2025 KuppingerCole Leadership Compass report for ITDR, securing the highest innovation rating. The Falcon platform’s AI-powered protection secures human, non-human, and AI agent identities across hybrid environments. Its strengths include unified PAM with JIT access and platform consolidation for ITDR, endpoint, and cloud defense. The platform addresses the growing need for comprehensive identity security as attacks increasingly target diverse digital identities. CrowdStrike emphasizes its ability to protect the entire hybrid identity attack chain.
-
Carpenter Technology Announces Proposed $700 Million Private Offering of 2034 Senior Notes
Carpenter Technology (NYSE: CRS) plans a private placement of $700 million in senior notes due 2034, targeting qualified institutional buyers and select non-U.S. investors. Net proceeds, combined with cash, will redeem 6.375% notes due 2028 and repay 7.625% notes due 2030, with remaining funds for general corporate purposes. The offering is subject to market conditions. The notes are not registered under the Securities Act. This announcement is not a redemption notice.
-
NiCE Announces Webcast of 2025 Capital Markets Day
NiCE will host a Capital Markets Day on November 17, 2025, to detail its long-term strategy, CX Innovation Roadmap (in partnership with Cognigy), and financial outlook. The event will explore NiCE’s AI-powered CX solutions and their impact on customer interactions. While NiCE emphasizes AI to transform CX and automate processes, it faces competition and must address concerns about data privacy and ethical AI practices. A live webcast and replay will be available on the company’s website.
-
Questcorp Mining Clarifies Private Placement Investment
Questcorp Mining (QQCMF) closed the first tranche of a private placement on Oct 24, 2025, raising $2.1M by issuing 14M+ units priced at $0.15. Each unit includes a share and a half warrant, exercisable at $0.20 until Oct 24, 2027. $2M is subject to a Sharing Agreement with Sorbie Bornholm LP, settled in 24 monthly tranches based on a 20-day VWAP benchmarked against $0.1949. This could result in variable monthly proceeds.
-
QIAGEN Presents QIAsymphony Connect & Oncology Innovations at AMP 2025
QIAGEN announced the early access launch of QIAsymphony Connect, its next-generation automated nucleic acid purification platform at AMP 2025, with full release expected in mid-2026. The new platform features enhanced speed, traceability, and connectivity for liquid biopsy applications. QIAGEN also showcased Sample to Insight workflows for comprehensive genomic profiling via a partnership with Element Biosciences and highlighted HRD assay development in collaboration with Myriad Genetics Inc., solidifying its focus on precision oncology.
-
Leishen Energy Debuts at ADIPEC, Expanding into Middle East and International Markets
Leishen Energy (LSE) announced strategic initiatives at ADIPEC 2025 to expand its Middle East presence and accelerate international growth. Highlights include a supply agreement with an Abu Dhabi distributor positioning Leishen within the ADNOC supplier network, offering equipment, maintenance, and leasing services. Discussions focused on Eurasian partnerships (Azerbaijan, Turkey). Leishen secured authorization to manufacture Cooper engine models (MH/GS series) effective Nov 5, 2025, reducing production costs and delivery times for China and the Middle East.
-
Faraday Future: FX Super One Pilot Production Imminent; Parts Arrival Anticipated This Month
Faraday Future (FFAI) aims to begin FX Super One parts shipments by November 15, 2025, targeting pilot production by year-end, pending funding and permits. The company filed a patent for a blockchain/Web3 car-sharing system. Q3 2025 results are scheduled for release on November 13, 2025. A tariff reduction could improve costs. Investors are advised to monitor shipment arrival, customs clearance, assembly milestones, and financing updates for execution signals.